NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
CytomX Therapeutics, Inc. (NASDAQ:CTMX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=8055&wire=1
Lead Plaintiff Deadline: July 20, 2020
Class Period: May 17, 2018 - May 13, 2020
Allegations against CTMX include that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Enphase Energy, Inc. (NASDAQ:ENPH)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/enphase-energy-inc-loss-submission-form?prid=8055&wire=1
Lead Plaintiff Deadline: August 17, 2020
Class Period: February 26, 2019 - June 17, 2020
Allegations against ENPH include that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
The GEO Group, Inc. (NYSE:GEO)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/the-geo-group-inc-loss-submission-form?prid=8055&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: February 27, 2020 - June 16, 2020
Allegations against GEO include that: (i) GEO Group maintained woefully ineffective COVID-19 response procedures; (ii) those inadequate procedures subjected residents of the Company's halfway houses to significant health risks; (iii) accordingly, the Company was vulnerable to significant financial and/or reputational harm; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong